Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.

Article Details

Citation

Toprakci M, Yelekci K

Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.

Bioorg Med Chem Lett. 2005 Oct 15;15(20):4438-46.

PubMed ID
16137882 [ View in PubMed
]
Abstract

Monoamine oxidase (EC1.4.3.4; MAO) is a mitochondrial outer membrane flavoenzyme that catalyzes the oxidation of biogenic amines. It has two distinct isozymic forms designated MAO-A and MAO-B, each displaying different substrate and inhibitor specificities. They are the well-known targets for antidepressant and neuroprotective drugs. Elucidation of the X-ray crystallographic structure of MAO-B has opened the way for molecular modeling studies. A series of experimentally tested (1-10) model compounds has been docked computationally to the active site of the MAO-B enzyme. The AutoDock 3.0.5 program was employed to perform automated molecular docking. The free energies of binding (DeltaG) and inhibition constants (K(i)) of the docked compounds were calculated by the Lamarckian Genetic Algorithm (LGA) of AutoDock 3.0.5. Excellent to good correlations between the calculated and experimental K(i) values were obtained.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
(R)-N-methyl-N-2-propynyl-1-indanamineAmine oxidase [flavin-containing] BKi (nM)600N/AN/ADetails
5-Hydroxy-N-Propargyl-1(R)-AminoindanAmine oxidase [flavin-containing] BKi (nM)17000N/AN/ADetails
IsatinAmine oxidase [flavin-containing] BKi (nM)3000N/AN/ADetails
PargylineAmine oxidase [flavin-containing] BKi (nM)1800N/AN/ADetails
RasagilineAmine oxidase [flavin-containing] BKi (nM)700N/AN/ADetails
SelegilineAmine oxidase [flavin-containing] BKi (nM)970N/AN/ADetails